Traditionally, red light therapy has primarily focused on the 660nm and 850nm peak LED wavelengths - this is primarily for economic reasons and not at all dictated by the strength of scientific evidence.
660nm and 850nm LED chips are used in other industries and are therefore easier to source and less expensive. Our goal is not to cut costs, but to build the best red light therapy devices on Planet Earth.
The inclusion of the carefully selected 'non-traditional' wavelengths in the MitoPRO X, such as 590nm, 630nm, 810nm and 830nm represents a significant advancement in light therapy that builds on simple foundational concepts.
If you have already heard of our incredibly popular and award winning MitoPRO+ Series, then you may be familiar with our reasoning for including 630nm and 830nm in the MitoPRO+ .Our aim was to better target the peak action spectra for the chromophore Cytochrome C Oxidase.
For a detailed discussion we suggest reading that article:
MitoPRO+ Series - Advanced Red & Near Infrared Light Therapy
The MitoPRO X levels up from the MitoPRO+ by adding in a small amount of 590nm for enhanced skin and nitric oxide benefits while swapping out 850nm with 810nm for better penetration, among other benefits.
Furthermore the MitoPRO X contains two chips per lens package (double the number of chips as the MitoPRO+) so the light panel can be made entirely red (590,630,600) entirely NIR (810/830) or 50% Red and 50% NIR.
Again, the MitoPRO X is not a 'watered down' multi-wavelength panel (using one small chip per lens package) like some copycats that have emerged in the marketplace.
